Your browser doesn't support javascript.
loading
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation.
Diral, Elisa; Mori, Silvia; Antolini, Laura; Abruzzese, Elisabetta; Le Coutre, Philipp; Martino, Bruno; Pungolino, Ester; Elena, Chiara; Bergamaschi, Micaela; Assouline, Sarit; Di Bona, Eros; Gozzini, Antonella; Andrade-Campos, Marcio; Stagno, Fabio; Iurlo, Alessandra; Pirola, Alessandra; Fontana, Diletta; Petiti, Jessica; Bonanomi, Maria Luisa; Crivori, Patrizia; Piazza, Rocco; Fava, Carmen; Gambacorti-Passerini, Carlo.
  • Diral E; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Mori S; Division of Hematology, San Gerardo Hospital, Monza, Italy.
  • Antolini L; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Abruzzese E; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Le Coutre P; San Eugenio Hospital, Rome, Italy.
  • Martino B; Department of Hematology and Oncology, Charité - Humboldt-Universität, Campus Virchow, Berlin, Germany.
  • Pungolino E; Hematology, Bianchi Melacrino Morelli Hospital, Reggio Calabria, Italy.
  • Elena C; Hematology, Niguarda Ca' Granda Hospital, Milan, Italy.
  • Bergamaschi M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Assouline S; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.
  • Di Bona E; Hematology Clinic, IRCSS AOU S. Martino-IST, University of Genoa, Genoa, Italy.
  • Gozzini A; Division of Haematology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Andrade-Campos M; Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Stagno F; Hematology, AOU Careggi, University of Firenze, Firenze, Italy.
  • Iurlo A; Haematology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Pirola A; Hematology, University of Catania, Catania, Italy.
  • Fontana D; Oncohematology Division, IRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Petiti J; GalSeq s.r.l., Bresso, Italy.
  • Bonanomi ML; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Crivori P; University of Turin, Turin, Italy; and.
  • Piazza R; Clioss s.r.l., Nerviano, Italy.
  • Fava C; Clioss s.r.l., Nerviano, Italy.
  • Gambacorti-Passerini C; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Blood ; 136(19): 2237-2240, 2020 11 05.
Article en En | MEDLINE | ID: mdl-32518953

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Privación de Tratamiento / Carga Tumoral / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Privación de Tratamiento / Carga Tumoral / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article